Ubiquitin Specific Peptidase 39 (USP39) Peptide
USP39
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN985993
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 22 jours ouvrables
Aperçu rapide pour Ubiquitin Specific Peptidase 39 (USP39) Peptide (ABIN985993)
Antigène
USP39
(Ubiquitin Specific Peptidase 39 (USP39))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-USP39 antibody (Catalog #: ARP38825_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- USP39 (Ubiquitin Specific Peptidase 39 (USP39))
-
Sujet
-
USP39 may play a role in mRNA splicing. It is unsure if the protein really exhibits hydrolase activity. It could be a competitor of ubiquitin C-terminal hydrolases
Alias Symbols: 65K, SAD1, CGI-21, HSPC332, SNRNP65
Protein Interaction Partner: ACVR1,C17orf79,CD2BP2,DDX23,DDX24,DHX38,EFTUD2,GAR1,MEPCE,NAA38,NOC3L,PA2G4,PRPF3,PRPF31,PRPF4,PRPF4B,PRPF6,PRPF8,RG9MTD1,RNMTL1,RPL22L1,RRP8,SART1,SART3,SNRNP200,SNRNP27,SNRNP40,TP53,TSR2,TXNL4A,USP12,ZRANB2
Protein Size: 565 -
Poids moléculaire
- 65 kDa
-
ID gène
- 10713
-
NCBI Accession
- NM_006590, NP_006581
-
UniProt
- Q53GS9
Antigène
-
Vous êtes ici:
